CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Ecor1 Capital, LLC sold $25.1M of Corvus Pharmaceuticals, Inc.
10% owner
Sold$25,059,900
$5.01Price
5,000,000Shares
−98%Stake
What CRVS did after the filing
- The stock from Mon, Oct 4 open, $4.75
- −22.2%
- S&P 500, same days
- +8.0%
Measured over 30 trading days, to the Nov 15 close.
Traded Thu, Sep 30. Filed Fri, Oct 1, 7:39 PM ET, after the close. Returns use the Oct 4 open and the Nov 15 close. Not investment advice.